An innovative keynote panel structure with two keynote speakers providing both researcher and patient/family perspectives:
- Kathy Hudson (National Institutes of Health)
- Isabel Jordan (Rare Disease Foundation)
The keynote address will feature two coordinated presentations, followed by an interactive discussion of the opportunities and challenges of the integration of new genomic technologies.
More information will be available shortly.